As of Jul 21
| +0.21 / +0.38%|
The 21 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 58.00, with a high estimate of 68.00 and a low estimate of 40.00. The median estimate represents a +4.22% increase from the last price of 55.65.
The current consensus among 24 polled investment analysts is to Buy stock in Bristol-Myers Squibb. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.